Search research articles
Contact Us
Filters
Showing results (21-30 of 435) with videos related to
Page
of 44
Sort By:
Current Rheumatology Reports
|
January 10, 2004
Outcome measures in osteoarthritis: randomized controlled trials
Vibeke Strand, Ariella Kelman
Clinical and Experimental Rheumatology
|
June 26, 2010
The impact of rheumatoid arthritis and treatment on patients' lives
Vibeke Strand, Dinesh Khanna
Arthritis Research & Therapy
|
February 24, 2009
Randomized controlled trial design in rheumatoid arthritis: the past decade
Vibeke Strand, Jeremy Sokolove
Nature Clinical Practice. Rheumatology
|
November 1, 2006
Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials
Ernesto Zatarain, Vibeke Strand
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies
Vibeke Strand, Bruce Crawford
Annals of the Rheumatic Diseases
|
October 1, 2016
Importance of 'meeting of the minds': patient-reported outcomes and MRI
Veena K Ranganath, Vibeke Strand
The American Journal of Managed Care
|
April 17, 2008
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials
Vibeke Strand, Jasvinder A Singh
The Journal of Rheumatology
|
September 3, 2011
Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus
Vibeke Strand, Alvina D Chu
The Journal of Rheumatology
|
December 7, 2007
Longterm treatment benefits are best reflected by patient reported outcomes
C Vibeke Strand, Bruce Crawford
Cleveland Clinic Journal of Medicine
|
December 2, 2004
A world without Vioxx: to COX-2 or not to COX-2?
Lee S Simon, Vibeke Strand
Page
of 44
Search research articles
Search
Showing results (21-30 of 435) with videos related to
Sort By:
Page
of 44
Current Rheumatology Reports
|
January 10, 2004
Outcome measures in osteoarthritis: randomized controlled trials
Vibeke Strand, Ariella Kelman
Clinical and Experimental Rheumatology
|
June 26, 2010
The impact of rheumatoid arthritis and treatment on patients' lives
Vibeke Strand, Dinesh Khanna
Arthritis Research & Therapy
|
February 24, 2009
Randomized controlled trial design in rheumatoid arthritis: the past decade
Vibeke Strand, Jeremy Sokolove
Nature Clinical Practice. Rheumatology
|
November 1, 2006
Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials
Ernesto Zatarain, Vibeke Strand
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies
Vibeke Strand, Bruce Crawford
Annals of the Rheumatic Diseases
|
October 1, 2016
Importance of 'meeting of the minds': patient-reported outcomes and MRI
Veena K Ranganath, Vibeke Strand
The American Journal of Managed Care
|
April 17, 2008
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials
Vibeke Strand, Jasvinder A Singh
The Journal of Rheumatology
|
September 3, 2011
Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus
Vibeke Strand, Alvina D Chu
The Journal of Rheumatology
|
December 7, 2007
Longterm treatment benefits are best reflected by patient reported outcomes
C Vibeke Strand, Bruce Crawford
Cleveland Clinic Journal of Medicine
|
December 2, 2004
A world without Vioxx: to COX-2 or not to COX-2?
Lee S Simon, Vibeke Strand
Page
of 44